Happy 2025! We hope the new year is off to a good start for all our families. As mentioned in our last newsletter, the APS Type 1 Foundation will be sharing a number of resources leading up to Rare Disease Day on February 28th. Rare Disease Day (video link) is celebrated worldwide to raise awareness…
Read MoreIT’S NOT TOO LATE TO GIVE
We are deeply grateful for the incredible generosity shown this Giving Tuesday, with over 60 individuals coming together to make a meaningful impact through their contributions. Giving Tuesday may have passed, but there’s still time to participate in the giving season. You might be thinking, “I have no idea what to do.” Don’t worry—you’re in…
Read MoreINDO-US BRIDGING RARE SUMMIT MEETS IN DELHI, INDIA
Representing the APS Type 1 Foundation, Board Member Pushpa Rao exhibited a poster on APS Type 1 at the Indo-US Bridging Rare Summit in Delhi, India, seeking to expand the network, include more patients of Indian origin in our APS Type 1 (APECED) Registry, and inspire research that benefits all. Over two and a half…
Read MoreRARE DISEASE DAY 2025: FRIDAY, FEBRUARY 28
APS Type 1 is considered a “rare disease” because it affects fewer than 1 in 2,000 people. However, with over 6,000 conditions meeting this definition, rare diseases are anything but rare. Rare Disease Day provides a yearly opportunity to raise awareness of the 300 million people worldwide living with rare diseases. Learn more about specific…
Read MoreA SEASON OF GRATITUDE: CELEBRATING 10 YEARS OF THE APS TYPE 1 FOUNDATION
The holiday season is here – a time for gratitude, celebration, and reflection. This year is especially meaningful as we mark the 10th anniversary of the APS Type 1 Foundation. Join us as we look back on a decade of progress and hope for the future. Wow, where did this year go? This time of…
Read MoreAN ANNIVERSARY CELEBRATION IN SUPPORT OF THE APS TYPE 1 FOUNDATION
Congratulations to Kevin and Jamie on their 30th wedding anniversary. This milestone is not just a celebration of their enduring love and partnership but also a testament to their commitment to making a difference in the lives of others. In lieu of traditional gifts, Kevin and Jamie chose to channel their celebration into a cause…
Read MoreTHE POWER OF MANY
You have the power to make a significant impact on the future of the APS Type 1 community by engaging with the networks of family, friends, employers, coworkers, and community members around you. Today, we are celebrating four stories that we hope will inspire you to harness the collective power of many. READ MORE
Read MoreDAVE’S RESEARCH CORNER: BACK TO SCHOOL
As many in our community return to school or start a new academic year, it is important for students and their families to be well-prepared. This is especially crucial for those transitioning into elementary school, middle or junior high, high school, or college. To support a smooth and successful school year for individuals with APS…
Read MoreWELCOME OUR NEWEST BOARD MEMBER
We are pleased to announce that Gaby Talarico has joined our board, adding another valuable patient voice to guide and inform our work. Now approaching 30 years old, Gaby was diagnosed with APS Type 1 at the age of 11 and was the first participant in the Natural History Study at the National Institutes of…
Read MoreOUR SINCERE GRATITUDE TO HEATHER TALARICO FOR HER YEARS OF SERVICE
As Heather Talarico retires from our board of directors, the APS Type 1 Foundation extends its heartfelt gratitude to Heather for her dedicated service to our community over many years. As a co-founder of the Foundation, Heather has been a driving force behind our success. Her relentless efforts, including a decade of organizing the Driving…
Read MoreMark Anderson Named 2024 Recipient of the prestigious Coley Award
Diabetes Center Director, UCSF, Mark Anderson MD PhD has been awarded the prestigious Coley Award from the Cancer Research Institute. The Coley Award honors groundbreaking contributions to cancer research, validating and highlighting the impact of innovative work, particularly in immunotherapy and recognizes Dr. Anderson’s foundational contributions to the understanding of immune tolerance mechanisms, self-antigen presentation,…
Read More